Quantcast

Posts related to ‘FDA’

Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)

Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be.  It often traded huge volume around drug approval or study news, and shares ...
Read Full Story »

VioPharma Runs Into FDA & FTC Troubles Over Staph Drug (VPHM)

ViroPharma Incorporated (NASDAQ: VPHM) is getting crushed on news that the Food & Drug Administration has denied the petition filed by ViroPharma on March 17, 2006 related to the FDA's ...
Read Full Story »

VIVUS Faces Shareholder Risks After FDA Delay On Obesity Pill (VVUS, ARNA, OREX)

VIVUS Inc. (NASDAQ: VVUS) is getting a bit of a haircut this morning on the heels of some news from the Food & Drug Administration which may throw up some ...
Read Full Story »

Thoratec Clarifies Recall News (THOR)

There is good news and bad news on Thoratec Corporation (NASDAQ: THOR) today.  The bad news is that it did have a FDA news recall of its HeartMate II® Left Ventricular ...
Read Full Story »

How Do You Recall Heart Devices? (THOR)

Thoratec Corporation (NASDAQ: THOR) took it on the chin today after news came out about the Food & Drug Administration recalling the company's HeartMate II as the left ventricular-assist system.  What is interesting ...
Read Full Story »

Potential Deathblow for Chelsea (CHTP)

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is being beaten hard this morning.  News hit that the FDA has now rejected the company's Northera drug to treat low blood pressure for ...
Read Full Story »

Diabetes Drug Approved For Europe (AMLN, LLY)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) and Eli Lilly & Co. (NYSE: LLY) are in the news on the diabetes front.  The companies have announced that the European Commission has now ...
Read Full Story »

The Generic Boniva Opportunity (RHHBY, MYL)

The Food and Drug Administration approval of the first generic versions of osteoporosis drug Boniva won't be the end of Roche Holding AG (OTC: RHHBY) for its marketing of Boniva in the ...
Read Full Story »

Another Boost For Threshold (THLD)

Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) has been one of the top performing stocks of 2012.  Not just in emerging pharma and in biotech, but across the board.  Now we have ...
Read Full Story »

Walmart Decides to Cut Sales of Unhealthy Foods

Instead of admitting that it has, in the past, sold food with too much sodium, salt and sugar, Walmart (NYSE: WMT) has made a public relations bonanza of its decision ...
Read Full Story »

Winners as Pfizer Loses Lipitor Patent (PFE, TEVA, MYL, WPI)

Pfizer Inc. (NYSE: PFE) has a big day ahead of it.  While it has been known for years, it is a massive date: Lipitor goes off-patent and will have generic ...
Read Full Story »

Why “Sell the News” on Seattle Genetics (SGEN)

There is an old rule of thumb from biotech investors and traders... SELL FDA APPROVALS.  This is very counter-intuitive on the surface but we wanted to explain in more detail ...
Read Full Story »

Opinions Vary on Impact of New FDA Cigarette Warning Labels (RAI, LO, PM)

If you have seen the graphic images that will go on cigarette packages late in 2011, you might think that the tobacco companies have finally met their match.  The graphic ...
Read Full Story »

Beyond Dodd-Frank… Frank-Paul Marijuana Legalization Legislation? (MO, RAI, BUD, TAP, PEP)

If Altria Group Inc. (NYSE: MO), Reynolds American Inc. (NYSE: RAI), Anheuser-Busch InBev (NYSE: BUD), and Molson Coors Brewing Company (NYSE: TAP)  should keep an eye on efforts to legalize ...
Read Full Story »

FDA Cigarette Warnings Getting More Harsh Than Europe (MO, RAI, LO, VGR, PFE)

The FDA is about to give some serious warning labels on cigarette labels.  Altria Group Inc. (NYSE: MO), Reynolds American Inc. (NYSE: RAI), Lorillard, Inc. (NYSE: LO)  and Vector Group ...
Read Full Story »